Adjusted odds-ratios for the presence of any CHIK virus antibody according to demographic characteristics of individuals aged ≥15 years, Mayotte, 2005–2006.
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Contact data of two cross-sectional, sero-epidemiological studies in the general population of the Netherlands: The Pienter3 study (2016-2017) The PienterCorona (PiCo) study consisting of 10 rounds (
